Curative was founded in 2020 by Fred Turner and Dr. Isaac Turner. The company has not publicly endorsed plans to participate in an IPO.
Curative is a healthcare company that specializes in offering affordable and transparent health insurance plans for businesses. In 2022, Curative acquired Wingspan Health, an app-based medical record management platform. The company has raised more than $8 million in venture capital funding from investors including DCVC and Refactor Capital. Curative has not disclosed valuation figures.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/23/2020 | Series A-5 | $49,994.00 | $xx.xx | $37.8MM | Chris Anderson, Dcvc, Refactor Capital | |
Price per Share
$xx.xx
Shares Outstanding
693,200
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chris Anderson, Dcvc, Refactor Capital
|
||||||
09/23/2020 | Series A-2 | $100,000.00 | $xx.xx | $37.8MM | Chris Anderson, Dcvc, Refactor Capital | |
Price per Share
$xx.xx
Shares Outstanding
8,999,900
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chris Anderson, Dcvc, Refactor Capital
|
||||||
09/23/2020 | Series A-1 | $100,000.00 | $xx.xx | $37.8MM | Chris Anderson, Dcvc, Refactor Capital | |
Price per Share
$xx.xx
Shares Outstanding
23,999,800
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chris Anderson, Dcvc, Refactor Capital
|
||||||
09/23/2020 | Series A-4 | $869,987.00 | $xx.xx | $37.8MM | Chris Anderson, Dcvc, Refactor Capital | |
Price per Share
$xx.xx
Shares Outstanding
39,149,300
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chris Anderson, Dcvc, Refactor Capital
|
||||||
09/23/2020 | Series A-6 | $1.1MM | $xx.xx | $37.8MM | Chris Anderson, Dcvc, Refactor Capital | |
Price per Share
$xx.xx
Shares Outstanding
32,999,800
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chris Anderson, Dcvc, Refactor Capital
|
||||||
09/23/2020 | Series A-3 | $1.2MM | $xx.xx | $37.8MM | Chris Anderson, Dcvc, Refactor Capital | |
Price per Share
$xx.xx
Shares Outstanding
71,999,600
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chris Anderson, Dcvc, Refactor Capital
|
||||||
09/23/2020 | Series A | $2.51MM | $xx.xx | $37.8MM | Chris Anderson, Dcvc, Refactor Capital | |
Price per Share
$xx.xx
Shares Outstanding
29,553,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chris Anderson, Dcvc, Refactor Capital
|
||||||
09/23/2020 | Series A-7 | $2.86MM | $xx.xx | $37.8MM | Chris Anderson, Dcvc, Refactor Capital | |
Price per Share
$xx.xx
Shares Outstanding
65,392,700
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chris Anderson, Dcvc, Refactor Capital
|